Therapeutic options for elderly diabetic subjects: Open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs

Acta Diabetologica

Volumn 45, Issue 1, 2008, Pages 53-59

  Papa, G ^a   Fedele, V ^c   Chiavetta, A ^d   Lorenti, I ^d   Leotta, C ^c   Luca, S ^c   Rabuazzo, A M ^a,b   Piro, S ^a,b   Alagona, C ^a,b   Spadaro, L ^a,b   Purrello, F ^a,b   Pezzino, V ^a,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

^c UO of Geriatry   (Italy)

^d CANNIZZARO HOSPITAL   (Italy)

Author keywords

Elderly; Glargine; Hypoglycemia; Oral antidiabetics; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; INSULIN GLARGINE; METFORMIN; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE;

AGED; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIABETIC PATIENT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TITRIMETRY;

ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARBAMATES; DRUG THERAPY, COMBINATION; FEMALE; GLICLAZIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; PIPERIDINES; RESEARCH DESIGN; THIAZOLIDINEDIONES;

EID: 39149091708     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0023-6     Document Type: Article

References (23)

1. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD (1998) Prevalence of diabetes, IFG and IGT in U.S. adults. The third national health and nutrition examination survey, 1988-94. Diabetes Care 21(4):518-524
2. Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, Schreiner PJ, Margolis KL, Cauley JA, Nevitt MC, Black DM, Cummings SR (2002) Older woman with diabetes have a higher risk of falls: a prospective study. Diabetes Care 25(10):1749-1754
3. Songer TJ (1995) Disability in diabetes. In: Harris MI, Cowie CC, Stern MP et al (eds) Diabetes in America, 2nd edn. National Institutes of Health, Bethesda, pp 259-282
4. Brown AF, Mangione CM, Saliba D, Sarkisian CA (2003) California healthcare foundation/American geriatrics society panel on improving care for elders with diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51(5 Suppl Guidelines):S265-S280
5. Peyrot M, Rubin RR (1997) Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20(4):585-590
6. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR (2000) Is diabetes associated with cognitive impairment and cognitive decline among older woman? Study of osteoporotic fractures research group. Arch Intern Med 160(2):174-180
7. Shorr RI, Franse LV, Resnick HE et al (2000) Glycemic control of older adults with type 2 diabetes: findings from the third national health and nutrition examination survey, 1988-1994. J Am Geriatr Soc 48(3):264-267
8. American Diabetes Association (2006) Standards of medical care for patients with diabetes mellitus. Diabetes Care 26(Suppl 1):S33-S50
9. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA (1997) Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20:135-141
10. Shorr RI, Ray WA, Daugherty JR, Griffin MR (1997) Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157:1681-1686
11. Janka HU, Plewe G, Busch K (2007) Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus. J Am Geriatr Soc 55(2):182-188
12. Bolli GB, Owens DR (2000) Insulin glargine (commentary). Lancet 356:443-444
13. Rosenstock J, Schawartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB (2001) Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE901) and NPH insulin. Diabetes Care 24:631-636
14. Hamann A, Matthaei S, Rosak C, Silestre L; HOE901/4007 Study Group (2003) A randomized clinical trial comparing breakfast, dinner or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 26(6):1738-1744
15. Riddle MC, Rosenstock J, Gerich J (2003) Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. The treat-to-target trial. Diabetes Care 26:3080-3086
16. Yki-Jarvinen H, Dressler A, Ziemen M; HOE 901/300s Study Group (2000) Less nocturnal hypoglycaemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 23:1130-1136
17. Taskinen MR, Sane T, Helve E, Karonen SL, Nikkita EA, Yki-Jarvinen H (1989) Bedtime insulin for suppression of overnight free fatty acid, blood glucose, and glucose production in NIDDM. Diabetes 38:580-588
18. Riddle MC (1990) Evening insulin strategy. Diabetes Care 13:676-686
19. Shank ML, Del Prato S, DeFronzo RA (1995) Bedtime insulin/daytime glipizide: effective therapy for sulfonylurea failures in NIDDM. Diabetes 44:165-172
20. Janka HU, Plewe G, Riddle MC et al (2005) Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 28:254-259
21. Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G (2006) On behalf of the insulin glargine 4014 study investigators. Triple therapy in type 2 diabetes. Diabetes Care 29:554-559
22. Holstein A, Plaschke A, Egberts EH (2003) Clinical characterisation of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes 111:364-369
23. Lager E (2005) Weight gain and insulin treatment. Diabetes Metab 31(4 Pt 2):4S54-4S56